Bionorica

Bionorica SE is one of the leading companies in the global botanical drug field. The product range mainly focuses on medications for respiratory diseases, urinary tract diseases, gynecological conditions, and pain treatment. As an essential biological response, it adheres to botanical principles as the gold standard of modern phytotherapy. Phytoneering combines the immense potential of natural active substances (plants) with the knowledge and methods of modern pharmaceutical research (engineering) to develop effective and safe formulations. The stated goal is to discover new active substances to develop effective drugs with minimized side effects. In 2010, Bionorica AG transitioned into a European public limited-liability company: Bionorica SE.